EPRX Earnings Date: Nov 3, 2026 (Estimated) — Eupraxia Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is EPRX's next earnings date?
Eupraxia Pharmaceuticals Inc. (EPRX) is expected to report Q3 2026 earnings on Tuesday, November 3, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.26.
How did EPRX do in its last earnings report?
In its most recent report on Aug 11, 2026 (Q2 2026), Eupraxia Pharmaceuticals Inc. posted EPS of -$0.23 versus the -$0.23 estimate, a miss of 0.0%. Revenue was $0. The stock's 1-day post-earnings move was -3.3%.
How much does EPRX stock move after earnings?
EPRX beat EPS estimates in 1 of its last 6 reported quarters. Over the last 7 reports the stock moved an average of 2.2% (up or down) in the day after earnings.
About Eupraxia Pharmaceuticals Inc.
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. The company's product portfolio includes EP-104IAR, which is in Phase III clinical trial for the treatment of knee osteoarthritis; EP-104GI that is in Phase II clinical trial for treating eosinophilic esophagitis; and EP-104, which is under preclinical studies for the treatment of gastrointestinal tract, such as eosinophilic esophagitis. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 | Q2 2026 | -0.23 | -0.23 | +0.00% | $0 | ❌ Miss | -3.28% | +2.24% | +19.70% |
| 2026-05-12 | Q1 2026 | -0.20 | -0.23 | -15.00% | $0 | ❌ Miss | -0.79% | -17.35% | -20.76% |
| 2026-03-12 | Q4 2025 | -0.16 | -0.37 | -131.25% | $0 | ❌ Miss | -1.87% | +1.33% | -4.27% |
| 2025-11-04 | Q3 2025 | -0.21 | -0.19 | +9.52% | $0 | ✅ Beat | +4.04% | +19.82% | +7.71% |
| 2025-08-12 | Q2 2025 | -0.19 | -0.26 | -36.84% | $0 | ❌ Miss | +1.42% | +0.31% | +1.80% |
| 2025-03-20 | Q4 2024 | — | -0.22 | — | $0 | — | -2.24% | -13.53% | -11.00% |
| 2024-11-07 | Q3 2024 | — | -0.17 | — | $0 | — | +1.63% | -8.32% | +4.96% |
| 2022-12-30 | -0.13 | -0.41 | — | — | ❌ Miss | — | — | — |
Showing last 8 quarters.